TrialMedical oncology (Northwood, London, England)2015

A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors.

Pei Shu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.